ZHAOKE OPHTH-B News

Zhaoke Ophthalmology Procures Distributor for Presbyopia Drug in Australia, New Zealand

MT NewswiresJan 13 07:16 ET

Express News | Zhaoke Ophthalmology Ltd - Entering Into Distribution- Agreement With AFT Pharmaceuticals

ReutersJan 13 04:41 ET

Express News | Zhaoke Ophthalmology - Nmpa Acceptance of Abbreviated New Drug- Application for Nvk002 for Treatment of- Myopia Progression in Children

ReutersJan 2 05:40 ET

Express News | Zhaoke Ophthalmology - Marketing Authorizations Obtained From Nmpa for Latanoprost Eye Drop, Travoprost Eye Drop, and Travoprost Timolol Eye Drop

ReutersDec 9, 2024 04:23 ET

Zhaoke Ophthalmology's Phase 3 Trial of Myopia Progression Drug Shows Positive Results

MT NewswiresOct 23, 2024 08:50 ET

Zhaoke Ophthalmology Completes Last Patient Visit for Trial of Macular Degeneration Drug

MT NewswiresSep 26, 2024 06:01 ET

Zhaoke Ophthalmology Glaucoma Eye Drops Get Marketing Approval; Shares Rise 3%

MT NewswiresSep 19, 2024 22:28 ET

Express News | Zhaoke Ophthalmology Ltd - Marketing Authorization for Bimatoprost Eye Drop (®) Obtained From Nmpa

ReutersSep 19, 2024 18:11 ET

Zhaoke Ophthalmology Expects Losses to Shrink in H1

MT NewswiresAug 15, 2024 03:35 ET

Express News | Corrected-Zhaoke Ophthalmology H1 Net Income RMB -77 Million (Corrects Amount)

ReutersAug 14, 2024 10:40 ET

Express News | Zhaoke Ophthalmology - Expected Result Due to Decrease in Research and Development Expenses Associated With Nvk002 and Tab014, Among Others

ReutersAug 14, 2024 10:35 ET

Express News | Zhaoke Ophthalmology Sees Loss of No More Than RMB77 Mln for Six Months

ReutersAug 14, 2024 10:34 ET

Express News | Zhaoke Ophthalmology H1 Net Income RMB -233.7 Million

ReutersAug 14, 2024 10:34 ET

Zhaoke Ophthalmology's Investigational NDA for Dry Eye Disease Drug Approved by Chinese Regulator

MT NewswiresAug 13, 2024 05:32 ET

Express News | Zhaoke Ophthalmology - Approval of Investigational New Drug Application for Phase III Clinical Trial of Cyclosporine a (Csa) Ophthalmic Gel by Nmpa

ReutersAug 11, 2024 19:54 ET

Zhaoke Ophthalmology Grants 4.6 Million Share Options

MT NewswiresJul 4, 2024 03:27 ET

Zhaoke Ophthalmology Shrinks Loss in 2023

MT NewswiresApr 29, 2024 06:39 ET

Zhaoke Ophthalmology Grants Kwangdong Pharma Rights to Distribute Eye Drop in Korea

MT NewswiresJan 29, 2024 06:46 ET

Zhaoke Ophthalmology Limited's (HKG:6622) Last Week's 26% Decline Must Have Disappointed Individual Investors Who Have a Significant Stake

Simply Wall StJan 5, 2024 18:22 ET

Zhaoke Ophthalmology's Myopia Treatment Shows Strong Safety, Efficacy in Phase 3 Study

MT NewswiresOct 12, 2023 22:30 ET